Aspidon: 1 mg: Risperidone is indicated for the management of psychotic disorders and nonpsychotic symptoms associated with dementia in the elderly.
2 mg: Risperidone (Aspidon) is indicated for the treatment of schizophrenia, and for the short-term treatment of acute manic or mixed episodes associated with bipolar disorders.
Aspidon OS: Risperidone (Aspidon OS) is indicated for the treatment of schizophrenia, moderate to severe manic episodes associated with bipolar disorders and for short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.
Risperidone (Aspidon OS) is indicated for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to DSM-IV criteria, in whom the severity of aggressive or other disruptive behaviors require pharmacologic treatment. Pharmacological treatment should be an integral part of a more comprehensive treatment program, including psychosocial and educational intervention. It is recommended that Risperidone (Aspidon OS) be prescribed by a specialist in child neurology and child and adolescent psychiatry or physicians well familiar with the treatment of conduct disorder of children and adolescents.